Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.8 SEK
233.97 M SEK
882.85 M SEK
34.86 M
About SURGICAL SCIENCE SWEDEN AB
Sector
Industry
CEO
Tom Englund
Website
Headquarters
Gothenburg
Founded
1997
ISIN
SE0014428512
FIGI
BBG00GSNPLH1
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, for procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SUS is 145.5 SEK — it has increased by 0.85% in the past 24 hours. Watch SURGICAL SCIENCE SWEDEN AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange SURGICAL SCIENCE SWEDEN AB stocks are traded under the ticker SUS.
SUS stock has risen by 10.41% compared to the previous week, the month change is a 13.65% rise, over the last year SURGICAL SCIENCE SWEDEN AB has showed a −6.55% decrease.
We've gathered analysts' opinions on SURGICAL SCIENCE SWEDEN AB future price: according to them, SUS price has a max estimate of 225.00 SEK and a min estimate of 165.00 SEK. Watch SUS chart and read a more detailed SURGICAL SCIENCE SWEDEN AB stock forecast: see what analysts think of SURGICAL SCIENCE SWEDEN AB and suggest that you do with its stocks.
SUS stock is 3.99% volatile and has beta coefficient of 0.74. Track SURGICAL SCIENCE SWEDEN AB stock price on the chart and check out the list of the most volatile stocks — is SURGICAL SCIENCE SWEDEN AB there?
Today SURGICAL SCIENCE SWEDEN AB has the market capitalization of 7.25 B, it has increased by 2.53% over the last week.
Yes, you can track SURGICAL SCIENCE SWEDEN AB financials in yearly and quarterly reports right on TradingView.
SURGICAL SCIENCE SWEDEN AB is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
SUS earnings for the last quarter are 0.84 SEK per share, whereas the estimation was 0.73 SEK resulting in a 14.48% surprise. The estimated earnings for the next quarter are 1.03 SEK per share. See more details about SURGICAL SCIENCE SWEDEN AB earnings.
SURGICAL SCIENCE SWEDEN AB revenue for the last quarter amounts to 232.00 M SEK, despite the estimated figure of 231.06 M SEK. In the next quarter, revenue is expected to reach 264.72 M SEK.
SUS net income for the last quarter is 43.02 M SEK, while the quarter before that showed 28.57 M SEK of net income which accounts for 50.60% change. Track more SURGICAL SCIENCE SWEDEN AB financial stats to get the full picture.
No, SUS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 260.00 employees. See our rating of the largest employees — is SURGICAL SCIENCE SWEDEN AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SURGICAL SCIENCE SWEDEN AB EBITDA is 215.47 M SEK, and current EBITDA margin is 27.97%. See more stats in SURGICAL SCIENCE SWEDEN AB financial statements.
Like other stocks, SUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SURGICAL SCIENCE SWEDEN AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SURGICAL SCIENCE SWEDEN AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SURGICAL SCIENCE SWEDEN AB stock shows the neutral signal. See more of SURGICAL SCIENCE SWEDEN AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.